Press release content from Business Wire. The AP news staff was not involved in its creation.
PRESS RELEASE: Paid content from Business Wire
Press release content from Business Wire. The AP news staff was not involved in its creation.

Global Hemostasis & Tissue Sealing Agents Market: 2016-2019 Review and 2020-2026 Forecast - ResearchAndMarkets.com

November 21, 2019 GMT

DUBLIN--(BUSINESS WIRE)--Nov 21, 2019--

The “Global Hemostasis And Tissue Sealing Agents Market Analysis 2019” report has been added to ResearchAndMarkets.com’s offering.

The Global Hemostasis and Tissue Sealing Agents market is expected to reach $12.28 billion by 2026, growing at a CAGR of 10.7% during 2018 to 2026.

Some of the factors such as rising demand supported by increasing surgery volumes and FDA approval for numerous hemostatic products are fuelling the market growth. However, high prices of the products and stringent regulatory environment are restraining the market growth.

Based on Product, adhesive and tissue sealing agents segment has witnessed significant growth. Adhesive and tissue sealing agents play a important role in controlling blood loss during surgeries. They function by binding with and sealing the damaged tissues. Binding leads to the development of a barrier over the injuries and surgical wound and helps promote coagulation.

The key vendors mentioned are Advance Medical Solution (AMS) Group Plc, B Braun Medical Inc, Biomet Inc, C R Bard Inc, Cohera Medical Inc, Cohesion Technologies Inc, Covidien Plc, CryoLife Inc, HyperBranch Medical Technology, Integra Life Sciences Corporation, Johnson & Johnson, Pfizer Inc and Smith & Nephew.

Key Questions Answered in this Report

  • How this market evolved since the year 2016
  • Market size estimations, forecasts and CAGR for all the segments presented in the scope
  • Key Market Developments and financials of the key players
  • Opportunity Analysis for the new entrants
  • SWOT Analysis of the key players
  • Fastest growing markets analyzed during the forecast period

Key Topics Covered

1 Market Synopsis

2 Research Outline

3 Market Dynamics

3.1 Drivers

3.2 Restraints

4 Market Environment

4.1 Bargaining power of suppliers

4.2 Bargaining power of buyers

4.3 Threat of substitutes

4.4 Threat of new entrants

4.5 Competitive rivalry

5 Global Hemostasis And Tissue Sealing Agents Market, By Product

5.1 Introduction

5.2 Topical hemostats

5.3 Adhesive and Tissue Sealing Agents

6 Global Hemostasis And Tissue Sealing Agents Market, By End User

6.1 Introduction

6.2 Ambulatory Surgical Centers

6.3 Home Care Settings

6.4 Hospitals

7 Global Hemostasis And Tissue Sealing Agents Market, By Geography

7.1 North America

7.2 Europe

7.3 Asia Pacific

7.4 South America

7.5 Middle East & Africa

8 Strategic Benchmarking

9 Vendors Landscape

9.1 Advance Medical Solution (AMS) Group PLC

9.2 B Braun Medical Inc.

9.3 Biomet Inc.

9.4 C R Bard Inc.

9.5 Cohera Medical Inc.

9.6 Cohesion Technologies Inc.

9.7 Covidien PLC

9.8 CryoLife Inc.

9.9 HyperBranch Medical Technology

9.10 Integra Life Sciences Corporation

9.11 Johnson & Johnson

9.12 Pfizer Inc.

9.13 Smith & Nephew

For more information about this report visit https://www.researchandmarkets.com/r/slimi5

View source version on businesswire.com:https://www.businesswire.com/news/home/20191121005715/en/

CONTACT: ResearchAndMarkets.com

Laura Wood, Senior Press Manager


For E.S.T Office Hours Call 1-917-300-0470

For U.S./CAN Toll Free Call 1-800-526-8630

For GMT Office Hours Call +353-1-416-8900



SOURCE: Research and Markets

Copyright Business Wire 2019.

PUB: 11/21/2019 11:07 AM/DISC: 11/21/2019 11:07 AM